Europe Cannabis

Tilray Medical Receives Approval to Extend Market Authorization in Italy

Tilray Medical Receives Approval to Extend Market Authorization in Italy

Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that FL Group S.R.L. (“FL Group”), a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s medical cannabis oral solution THC25 across the country.

Tilray Medical Bolsters Market Leading Position in Europe with Market Authorization in Poland

Tilray Medical Bolsters Market Leading Position in Europe with Market Authorization in Poland

Tilray Medical, has received approval to commercialize its Tilray branded medical cannabis products in Poland expanding its product offering and distribution across pharmacies in Europe.

Tilray Medical Welcomes Government of Luxembourg Delegation Visit to European Campus in Portugal

Tilray Medical Welcomes Government of Luxembourg Delegation Visit to European Campus in Portugal

We are proud to host the Govt of Luxembourg and @sante_lu at our EU-GMP medical cannabis facility in Portugal. As demand for cannabis legalization grows across Europe, we are honoured to serve patients in Luxembourg and globally with high-quality cannabis. $TLRY